Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 183 results found. Search for [ Oxford corona vaccine ]

Results 100 to 120 of 183
BusinessToday.In
September 10, 2020
The fatality rate due to coronavirus has further dipped to 1.68 per cent whereas the recovery rate was recorded at 77.74 per cent


BusinessToday.In
New Delhi, September 9, 2020
British-Swedish bio-pharmaceutical firm AstraZeneca PLC, working with a team of the University of Oxford, has temporarily paused the clinical trial of its coronavirus vaccine in the UK after one of the volunteers developed an 'unexplained' illness. Serum Institute CEO, Adar Poonawalla, referred to the issue as unrelated and said that it would not impact the vaccine trials in India. Watch the video for more.Also Read: AstraZeneca pauses COVID-19 trials: In which countries are the trials taking place?


Rajeev Dubey
New Delhi, September 9, 2020
Serum Institute CEO, Adar Poonawalla, told BusinessToday that the Indian trials, which were being conducted on the Oxford vaccine, had not been stopped yet. AstraZeneca PLC, which is working with a team of the University of Oxford, on Wednesday decided to temporarily pause the clinical trial of its coronavirus vaccine after one of the volunteers in the UK developed an 'unexplained' illness. Watch the video for more.Also Read: India coronavirus vaccine trials 'not stopped yet': Serum's Adar Poonawalla after AstraZeneca halts global trials


BusinessToday.In
New Delhi, September 9, 2020
The government is planning to sell about 15-20 per cent of its stake in Indian Railway Catering and Tourism Corporation (IRCTC) in the current fiscal; Centre has allowed partial reopening of schools for students of classes 9 to 12 from September 21; Apple Inc on Tuesday scheduled a special event for Sept. 15, with fans and investors expecting a refresh in the lineup of some of the company's core products. Watch this and more on News Blast.Also Read: Don't panic! Oxford coronavirus vaccine trials halted not cancelled


BusinessToday.In
September 9, 2020
Total coronavirus cases have mounted to 43,70,129, while death toll has climbed to 73,890. COVID-19 case fatality rate has increased to 2.17 per cent. So far, 33,98,845 people have recuperated pushing the national recovery rate to 77.77 per cent


BusinessToday.In
September 9, 2020
Dr VK Paul informed the Russian government has approached India to facilitate the Phase-3 trial of their vaccine and also manufacture Sputnik V through Indian companies


BusinessToday.In
September 1, 2020
COVID-19 vaccine: The University of Oxford and AstraZeneca PLC has developed the first vaccine candidate to start the final round of testing of the coronavirus vaccine


BusinessToday.In
August 29, 2020
COVID-19 vaccine update: The expert group of the committee, headed by Dr. VK Paul, is also in contact with domestic as well as multinational vaccine makers to understand how soon a COVID-19 vaccine will be ready


BusinessToday.In
New Delhi, August 26, 2020
Delhi recorded 1,544 fresh coronavirus cases on Tuesday, the city's highest single-day spike in August till date, taking the tally to over 1.64 lakh, while the death toll from the disease mounted to 4,330, authorities said. Addressing the media on Wednesday, Delhi Chief Minister Arvind Kejriwal said that the state government is prepared to deal with the spike in cases and warned people who were avoiding from getting tested. Watch the video for more.Also Read: Coronavirus vaccine: Phase 2 trials of Oxford candidate start in India; two get vaccinated


BusinessToday.In
New Delhi, August 24, 2020
India could get its first COVID vaccine in 73 days according to senior official at Serum Institute. Covishield has been fast tracked by the govt. The Centre has already indicated to SII that it will directly procure the vaccines and is planning to immunise Indians for free. Watch the video for more.Also Read: Metro services may resume from September 1, reopening of school unlikely


BusinessToday.In
New Delhi, August 23, 2020
India is all set to get its first coronavirus vaccine with Serum Institute of India's (SII) 'Covishield', which will be commercialised in 73 days, as per the top official at the pharma company. Indians will be immunised free of cost under the National Immunisation Programme (NIP), as is the case with all other vaccines under the programme. Watch the video to find out more.


BusinessToday.In
August 21, 2020
Around 74.3% of patients have been discharged in India so far, and active cases stand at 23.82 per cent; the death tally accounts for 1.89 per cent of the total coronavirus cases


BusinessToday.In
August 20, 2020
Coronavirus cases in India: higher number of coronavirus cases can be attributed to the significant rise in daily COVID-19 tests; India conducted over 9 lakh tests in the past 24 hours


BusinessToday.In
August 15, 2020
Independence day: 'Today, in India, not one or two but three vaccines are in the stage of testing. As soon as there is a green signal from scientists, the country is prepared to produce it in large numbers,' PM Modi said


BusinessToday.In
August 12, 2020
The committee members will take the decision on vaccines that will be effective for Indian citizens. The task force will also chalk out a budget and discuss how capital can be raised for procurement, distribution of the vaccine


BusinessToday.In
August 11, 2020
COVID-19 vaccine: The committee has the responsibility of financing, buying, distribution and administration of the coronavirus vaccine


BusinessToday.In
August 8, 2020
Coronavirus vaccine update: Serum Institute of India might begin its Phase 2 and 3 clinical trials in India within a week. Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate are going on in the United Kingdom, phase 3 clinical trial in Brazil


BusinessToday.In
August 7, 2020
The spike of coronavirus past the 20-lakh mark has made India inch closer to become the ground zero of COVID-19 outbreak


BusinessToday.In
August 2, 2020
Coronavirus vaccine: The Russian vaccine has raised concerns because of the speed at which it is being pushed through. However, the Russian Defence Ministry clarified that tests of the vaccine against coronavirus were conducted in full compliance with methodological regulations


BusinessToday.In
July 31, 2020
Coronavirus update: This is the second straight day that India has reported over 50,000 new cases in 24 hours; gap between recoveries and active cases increases to 5.12 lakh


PAGES 6 OF 10  678910